BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31757981)

  • 1. Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes.
    Pacicca DM; Brown T; Watkins D; Kover K; Yan Y; Prideaux M; Bonewald L
    Sci Rep; 2019 Nov; 9(1):17353. PubMed ID: 31757981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
    Li F; Cain JD; Tombran-Tink J; Niyibizi C
    J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
    Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
    PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
    Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
    J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis.
    Kim JH; Kim AR; Choi YH; Jang S; Woo GH; Cha JH; Bak EJ; Yoo YJ
    PLoS One; 2017; 12(12):e0189702. PubMed ID: 29240821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes.
    Gooi JH; Pompolo S; Karsdal MA; Kulkarni NH; Kalajzic I; McAhren SH; Han B; Onyia JE; Ho PW; Gillespie MT; Walsh NC; Chia LY; Quinn JM; Martin TJ; Sims NA
    Bone; 2010 Jun; 46(6):1486-97. PubMed ID: 20188226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
    Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
    J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.
    Silvestrini G; Ballanti P; Leopizzi M; Sebastiani M; Berni S; Di Vito M; Bonucci E
    J Mol Histol; 2007 Aug; 38(4):261-9. PubMed ID: 17549589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D
    Wijenayaka AR; Prideaux M; Yang D; Morris HA; Findlay DM; Anderson PH; Atkins GJ
    J Steroid Biochem Mol Biol; 2016 Nov; 164():369-373. PubMed ID: 26690786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
    Pereira M; Gohin S; Lund N; Hvid A; Smitham PJ; Oddy MJ; Reichert I; Farlay D; Roux JP; Cleasby ME; Chenu C
    Osteoporos Int; 2017 Jan; 28(1):309-320. PubMed ID: 27468901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size.
    Kogawa M; Khalid KA; Wijenayaka AR; Ormsby RT; Evdokiou A; Anderson PH; Findlay DM; Atkins GJ
    Am J Physiol Cell Physiol; 2018 Jan; 314(1):C53-C61. PubMed ID: 28978523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo.
    Woo SM; Rosser J; Dusevich V; Kalajzic I; Bonewald LF
    J Bone Miner Res; 2011 Nov; 26(11):2634-46. PubMed ID: 21735478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
    Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
    J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement.
    Shu R; Bai D; Sheu T; He Y; Yang X; Xue C; He Y; Zhao M; Han X
    PLoS One; 2017; 12(1):e0167312. PubMed ID: 28081119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Association Between Sclerostin and INSL3 in Isolated Human Osteocytes and in Klinefelter Syndrome: New Hints for Testis-Bone Crosstalk.
    Di Nisio A; De Toni L; Rocca MS; Ghezzi M; Selice R; Taglialavoro G; Ferlin A; Foresta C
    J Clin Endocrinol Metab; 2018 May; 103(5):2033-2041. PubMed ID: 29452406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis.
    Kim JH; Kim AR; Choi YH; Kim A; Sohn Y; Woo GH; Cha JH; Bak EJ; Yoo YJ
    J Transl Med; 2018 Mar; 16(1):70. PubMed ID: 29544500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
    Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
    Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.